Category Archives: pharmaceuticals
January 11, 2017 | FAH Policy Blog Team
Category: FAH News, Media, Pharmaceuticals
The website Healthcare Dive recently refocused the spotlight on the FAH/AHA hospital drug pricing study by publishing a feature article entitled, “How hospitals can fight the cost of budget-busting drugs.”
October 13, 2016 | FAH Policy Blog Team
Category: FAH News, Financing, Pharmaceuticals
A new analysis of drug pricing data released on October 11 got the attention of influential policymakers and garnered headlines nationwide after finding that hospital drug costs increased drastically over a two year period.
July 25, 2016 | FAH Policy Blog Team
Category: Health Care Delivery, Pharmaceuticals
The CEO of a hospital in rural Iowa expressed his support for common sense solutions to help solve the prescription drug pricing crisis in an op-ed published in Sunday’s Des Moines Register.
Phil Noel, CEO of Ottumwa Regional Health Center in Ottumwa Iowa, laid out how rising medication costs are effecting his hospital and the patients it serves.
“This problem is acute. The high cost of cancer drugs made it impossible for our organization to continue to offer medical oncology. Additionally, the boutique infusion drugs have increased in usage and cost with a high financial burden to patients and hospitals that administer them,” he wrote.
Ottumwa Regional Health Centers is owned by Federation of American Hospitals member company RCCH HealthCare Partners.
July 20, 2016 | FAH Policy Blog Team
Category: FAH News, Legislation, Pharmaceuticals
The Federation of American Hospitals commented to the Food and Drug Administration Monday on the agency’s latest detailed draft guidance document implementing provisions of the revised Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FAH letter expresses serious concerns about the current draft guidance and its impact on the provision of appropriate patient care.